Corton Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
+21,011
| New | +$364K | 0.42% | 43 |
|
|
2025
Q1 | – | Sell |
-7,595
| Closed | -$242K | – | 184 |
|
|
2024
Q4 | $242K | Sell |
7,595
-636
| -8% | -$20.3K | 0.14% | 194 |
|
|
2024
Q3 | $237K | Sell |
8,231
-5,325
| -39% | -$154K | 0.12% | 291 |
|
|
2024
Q2 | $520K | Buy |
+13,556
| New | +$520K | 0.27% | 43 |
|
|
2023
Q4 | – | Sell |
-6,083
| Closed | -$231K | – | 570 |
|
|
2023
Q3 | $231K | Buy |
+6,083
| New | +$231K | 0.12% | 269 |
|
|
2022
Q3 | – | Sell |
-5,606
| Closed | -$254K | – | 276 |
|
|
2022
Q2 | $254K | Buy |
+5,606
| New | +$254K | 0.24% | 176 |
|